These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19850926)

  • 41. Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis.
    Coulson-Thomas VJ; Gesteira TF; Esko J; Kao W
    J Biol Chem; 2014 Sep; 289(36):25211-26. PubMed ID: 25053416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
    Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
    Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
    Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro heparan sulfate polymerization: crucial roles of core protein moieties of primer substrates in addition to the EXT1-EXT2 interaction.
    Kim BT; Kitagawa H; Tanaka J; Tamura J; Sugahara K
    J Biol Chem; 2003 Oct; 278(43):41618-23. PubMed ID: 12907685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.
    Reijnders CM; Waaijer CJ; Hamilton A; Buddingh EP; Dijkstra SP; Ham J; Bakker E; Szuhai K; Karperien M; Hogendoorn PC; Stringer SE; Bovée JV
    Am J Pathol; 2010 Oct; 177(4):1946-57. PubMed ID: 20813973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling.
    Jia J; Maccarana M; Zhang X; Bespalov M; Lindahl U; Li JP
    J Biol Chem; 2009 Jun; 284(23):15942-50. PubMed ID: 19336402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokines and growth factors cross-link heparan sulfate.
    Migliorini E; Thakar D; Kühnle J; Sadir R; Dyer DP; Li Y; Sun C; Volkman BF; Handel TM; Coche-Guerente L; Fernig DG; Lortat-Jacob H; Richter RP
    Open Biol; 2015 Aug; 5(8):. PubMed ID: 26269427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2.
    Jackson RA; Murali S; van Wijnen AJ; Stein GS; Nurcombe V; Cool SM
    J Cell Physiol; 2007 Jan; 210(1):38-50. PubMed ID: 17051597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis.
    Senay C; Lind T; Muguruma K; Tone Y; Kitagawa H; Sugahara K; Lidholt K; Lindahl U; Kusche-Gullberg M
    EMBO Rep; 2000 Sep; 1(3):282-6. PubMed ID: 11256613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.
    Inubushi T; Lemire I; Irie F; Yamaguchi Y
    J Bone Miner Res; 2018 Apr; 33(4):658-666. PubMed ID: 29120519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signaling systems affecting the severity of multiple osteochondromas.
    Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
    Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural basis for heparan sulfate co-polymerase action by the EXT1-2 complex.
    Li H; Chapla D; Amos RA; Ramiah A; Moremen KW; Li H
    Nat Chem Biol; 2023 May; 19(5):565-574. PubMed ID: 36593275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.
    McCormick C; Duncan G; Goutsos KT; Tufaro F
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):668-73. PubMed ID: 10639137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparan sulfate is required for embryonic stem cells to exit from self-renewal.
    Kraushaar DC; Yamaguchi Y; Wang L
    J Biol Chem; 2010 Feb; 285(8):5907-16. PubMed ID: 20022960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.
    Naimy H; Buczek-Thomas JA; Nugent MA; Leymarie N; Zaia J
    J Biol Chem; 2011 Jun; 286(22):19311-9. PubMed ID: 21471211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
    Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
    Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditional ablation of heparan sulfate expression in stromal fibroblasts promotes tumor growth in vivo.
    Niwa A; Taniguchi T; Tomita H; Okada H; Kinoshita T; Mizutani C; Matsuo M; Imaizumi Y; Kuroda T; Ichihashi K; Sugiyama T; Kanayama T; Yamaguchi Y; Sugie S; Matsuhashi N; Hara A
    PLoS One; 2023; 18(2):e0281820. PubMed ID: 36809261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.
    Kim BT; Kitagawa H; Tamura J; Saito T; Kusche-Gullberg M; Lindahl U; Sugahara K
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7176-81. PubMed ID: 11390981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.
    Sinha S; Mundy C; Bechtold T; Sgariglia F; Ibrahim MM; Billings PC; Carroll K; Koyama E; Jones KB; Pacifici M
    PLoS Genet; 2017 Apr; 13(4):e1006742. PubMed ID: 28445472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.